NCT03002467

Brief Summary

The Investigator postulate that the use of PESI in addition to routine clinical practice, as opposed to routine clinical practice based on clinical judgment alone, will help physicians to correctly identify PE patients at low-risk of adverse outcomes. Considered that low-risk patients could benefit from a short hospital stay, aim of this study is to demonstrate that the use of PESI will lead physicians to discharge these patients earlier, thus reducing the duration of hospital stay of PE patients (primary outcome). Outpatients diagnosed with PE at the emergency department (ED) and admitted to participating units represent the target population As the availability of DOACs may influence the duration of hospital stay, the secondary objectives of the present study are:

  1. 1.to demonstrate that a shorter hospital stay for low-risk PE patients (independently on the method used to identify them) will reduce the incidence of hospital-associated complications and improve patients satisfaction and quality of life, without increasing the incidence of PE-related complications
  2. 2.to demonstrate that the use of PESI, as opposed to clinical judgment alone, will be associated with a greater proportion of patients discharged early (\< 72 hours from ED admission) or treated entirely at home (\< 24 hours from ED admission).
  3. 3.to demonstrate that the use of DOACs will reduce the duration of hospital stay of PE patients
  4. 4.to demonstrate that the use of DOACs, as opposed to standard treatment, will be associated with a greater proportion of patients discharged early (\< 72 hours from ED admission) or treated entirely at home (\< 24 hours from ED admission).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 11, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 23, 2016

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

November 17, 2020

Status Verified

November 1, 2020

Enrollment Period

3.2 years

First QC Date

December 11, 2016

Last Update Submit

November 13, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Length of hospital stay

    Up to 3 months

Study Arms (2)

PESI score

EXPERIMENTAL

treating physicians must formally calculate PESI and report in the clinical record form\* each day of hospitalization on top of routine clinical practice (standard care)

Other: PESI score

Standard care

NO INTERVENTION

standard care (i.e. no formally calculation of PESI on top)

Interventions

PESI score

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Outpatients with objectively diagnosed PE, both suspected or unsuspected (e.g. during CT for cancer staging and/or follow-up)
  • Age \> 18 years
  • Signature of written informed consent

You may not qualify if:

  • Children

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unknown Facility

Cuneo, Italy

Location

Related Publications (1)

  • Donadini MP, Mumoli N, Fenu P, Pomero F, Re R, Palmiero G, Spadafora L, Mazzi V, Grittini A, Bertu L, Aujesky D, Dentali F, Ageno W, Squizzato A. The Clinical Impact of the Pulmonary Embolism Severity Index on the Length of Hospital Stay of Patients with Pulmonary Embolism: A Randomized Controlled Trial. Diagnostics (Basel). 2024 Apr 7;14(7):776. doi: 10.3390/diagnostics14070776.

MeSH Terms

Conditions

Pulmonary Embolism

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesEmbolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Alessandro Squizzato, MD PhD

    Università degli Studi dell'Insubria

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 11, 2016

First Posted

December 23, 2016

Study Start

September 1, 2016

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

November 17, 2020

Record last verified: 2020-11

Locations